S 520 NY
Ensures ovarian cancer survivors have the right to access screenings for health conditions
A state bill is a proposed law in a state legislature — separate from the U.S. Congress. Learn more →
Summary
This bill prohibits denying ovarian cancer survivors access to genetic testing and genomic tumor profiling to identify inherited and acquired genetic mutations. Testing would not be subject to frequency caps or other limitations and would include screening for mutations in BRCA1 and BRCA2 genes, Lynch syndrome-related mutations, and rearrangement analysis of coding exons associated with ovarian cancer. The law would also permit testing for additional genetic mutations if medically necessary and appropriate, as determined by the treating healthcare professional. The bill takes effect immediately.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Official abstract
Ensures ovarian cancer survivors have the right to access screenings for health conditions.
Sponsor (1)
- Roxanne J. Persaud Democratic · primary
13 coauthors / cosponsors
- Joseph P. Addabbo Jr. Democratic · cosponsor
- George Borrello Republican · cosponsor
- Cordell Cleare Democratic · cosponsor
- Leroy Comrie Democratic · cosponsor
- Patricia Fahy Democratic · cosponsor
- Nathalia Fernandez Democratic · cosponsor
- Robert Jackson Democratic · cosponsor
- Dean Murray Republican · cosponsor
- Anthony H. Palumbo Republican · cosponsor
- Steve Rhoads Republican · cosponsor
- Robert Rolison Republican · cosponsor
- William Weber Republican · cosponsor
- Alexis Weik Republican · cosponsor
Action history (17)
- Jan 8, 2025 REFERRED TO WOMEN'S ISSUES · upper
- Mar 11, 2025 REPORTED AND COMMITTED TO FINANCE · upper
- May 29, 2025 COMMITTEE DISCHARGED AND COMMITTED TO RULES · upper
- May 29, 2025 ORDERED TO THIRD READING CAL.1461 · upper
- Jun 4, 2025 PASSED SENATE · upper
- Jun 4, 2025 DELIVERED TO ASSEMBLY · upper
- Jun 4, 2025 REFERRED TO HEALTH · lower
- Jan 7, 2026 DIED IN ASSEMBLY · lower
- Jan 7, 2026 RETURNED TO SENATE · lower
- Jan 7, 2026 REFERRED TO WOMEN'S ISSUES · upper
- Feb 25, 2026 REPORTED AND COMMITTED TO FINANCE · upper
- May 12, 2026 1ST REPORT CAL.1038 · upper
- May 13, 2026 2ND REPORT CAL. · upper
- May 14, 2026 ADVANCED TO THIRD READING · upper
- May 29, 2026 PASSED SENATE · upper
- May 29, 2026 DELIVERED TO ASSEMBLY · upper
- May 29, 2026 REFERRED TO HEALTH · lower
Text versions (2)
Full text
Full text imported from assembly.state.ny.us
Skip to main content
New York State Assembly Speaker Carl E. Heastie
--> --> -->
Assembly Members
Legislative Info
Public Hearings
Speaker's Press
Assembly Reports
Committees & More
Bill Search Home Laws Legislative Calendar Public Hearing Schedule Assembly Calendars Assembly Committee Agenda Javascript must be enabled to properly view this page.
Bill No.: Summary Actions Committee Votes Floor Votes Memo Text LFIN Chamber Video/Transcript S00520 Summary: BILL NO S00520   SAME AS SAME AS A00686
  SPONSOR PERSAUD   COSPNSR ADDABBO, BORRELLO, CLEARE, COMRIE, FAHY, FERNANDEZ, JACKSON, MURRAY, PALUMBO, RHOADS, ROLISON, WEBER, WEIK   MLTSPNSR   Add §2404-e, Pub Health L   Ensures ovarian cancer survivors have the right to access screenings for health conditions.
Go to top S00520 Text:
STATE OF NEW YORK ________________________________________________________________________
520
2025-2026 Regular Sessions
IN SENATE
(Prefiled)
January 8, 2025 ___________
Introduced by Sens. PERSAUD, BORRELLO, CLEARE, COMRIE, PALUMBO, ROLISON, WEBER, WEIK -- read twice and ordered printed, and when printed to be committed to the Committee on Women's Issues
AN ACT to amend the public health law, in relation to ensuring ovarian cancer survivors have the right to access screenings for health condi- tions
The People of the State of New York, represented in Senate and Assem- bly, do enact as follows:
1 Section 1. The public health law is amended by adding a new section 2 2404-e to read as follows: 3 § 2404-e. Ovarian cancer; right to screenings. No person with a 4 personal history of ovarian cancer shall be denied genetic testing or 5 genomic tumor profiling for inherited germline mutations and acquired 6 somatic mutations, respectively. In general, such testing shall not be 7 subject to frequency caps or other limitations and shall include, but 8 not be limited to: 9 (a) genetic mutations in BRCA1 and BRCA2 genes; 10 (b) genetic mutations associated with Lynch syndrome; 11 (c) rearrangement analysis of all coding exons associated with ovarian 12 cancer; and 13 (d) additional mutations if medically necessary and appropriate, as 14 determined by the health care professional treating the individual. 15 § 2. This act shall take effect immediately.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD02193-01-5
Go to top
Sitemap
Request Information
Directions and Maps
Comments
Data from OpenStates. View on OpenStates →
Comments